Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P3
Near historical low
vs 5Y Ago
-10.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -172.73% |
| Q2 2025 | 80.36% |
| Q1 2025 | -366.67% |
| Q4 2024 | 172.41% |
| Q3 2024 | 45.28% |
| Q2 2024 | 14.52% |
| Q1 2024 | 8.82% |
| Q4 2023 | 79.76% |
| Q3 2023 | -83.61% |
| Q2 2023 | 41.16% |
| Q1 2023 | 3.72% |
| Q4 2022 | 35.01% |
| Q3 2022 | 23.07% |
| Q2 2022 | -2.87% |
| Q1 2022 | -20.08% |
| Q4 2021 | -0.19% |
| Q3 2021 | 42.38% |
| Q2 2021 | -15.27% |
| Q1 2021 | 36.15% |
| Q4 2020 | -5.03% |
| Q3 2020 | 16.64% |
| Q2 2020 | 3.83% |
| Q1 2020 | 23.09% |
| Q4 2019 | 4.52% |
| Q3 2019 | 15.46% |
| Q2 2019 | 13.77% |
| Q1 2019 | -20.84% |
| Q4 2018 | -5.36% |
| Q3 2018 | 1.65% |
| Q2 2018 | -17.76% |
| Q1 2018 | 8.27% |
| Q4 2017 | -9.85% |
| Q3 2017 | 0.00% |